I'm curious as to how many Serelaxin managers were hired nationwide, and how many of the 46 LCZ positions will be auto-filled by the Serelaxin ABLs.
They didm't hire these cardiac specialist managers to get rid of them in a few months. They are here to stay. Interesting since there really isn't a product yet approved and Novartis isn't great with getting products through the FDA.
Sad but true. I unfortunately agree. They will probably fill LcZ ABL positions with them first. Then whatever is left over. Good luck to us all. Give me the package.